1. Schuh FT (1976) Zum molekularen Wirkmechanismus von Galanthamin, einem Curare-Antagonisten. Anaesthesist 25: 444?448
2. Thomsen T, Kewitz H (1990) Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo. Life Sci 46: 1553?1558
3. Thomsen T, Bickel U, Fischer JP, Kewitz H (1990) Galanthamine hydrobromide in a long-term treatment of Alzheimer's disease. Dementia 1: 46?51
4. Rainer M, Mark T, Haushofer A (1989) Galanthamine hydrobromide in the treatment of senile dementia of Alzheimer's type. In: Kewitz H, Thomsen T, Bickel U (eds) Pharmacological interventions on central cholinergic mechanisms in senile dementia. Zuckschwerdt, München pp 233?237
5. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical Diagnosis of Alzheimer's Disease. Report of the NINCDS-ADRDA Work Group Under the Auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939?944